dc.contributorUniv Vale Paraiba
dc.contributorSan Francisco Assis Hosp
dc.contributorCtr Diagnost Med Pathol & Cytol CIPAX
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-26T17:16:35Z
dc.date.available2018-11-26T17:16:35Z
dc.date.created2018-11-26T17:16:35Z
dc.date.issued2017-01-01
dc.identifierOncology Letters. Athens: Spandidos Publ Ltd, v. 13, n. 1, p. 488-496, 2017.
dc.identifier1792-1074
dc.identifierhttp://hdl.handle.net/11449/162410
dc.identifier10.3892/ol.2016.5438
dc.identifierWOS:000393018400074
dc.description.abstractNodal status is the most significant independent prognostic factor in breast cancer. Identification of molecular markers would allow stratification of patients who require surgical assessment of lymph nodes from the large numbers of patients for whom this surgical procedure is unnecessary, thus leading to a more accurate prognosis. However, up to now, the reported studies are preliminary and controversial, and although hundreds of markers have been assessed, few of them have been used in clinical practice for treatment or prognosis in breast cancer. The purpose of the present study was to determine whether protein phosphatase Mg2+/Mn2+ dependent 1D, beta-1,3-N-acetylglucosaminyltransferase, neural precursor cell expressed, developmentally down-regulated 9, prohibitin, phosphoinositide-3-kinase regulatory subunit 5 (PIK3R5), phosphatidylinosito1-5-phosphate 4-kinase type Ha, TRF1-interacting ankyrin-related ADP-ribose polymerase 2, BCL2 associated agonist of cell death, G2 and S-phase expressed 1 and PAX interacting protein 1 genes, described as prognostic markers in breast cancer in a previous microarray study, are also predictors of lymph node involvement in breast carcinoma Reverse transcription-quantitative polymerase chain reaction analysis was performed on primary breast tumor tissues from women with negative lymph node involvement (n=27) compared with primary tumor tissues from women with positive lymph node involvement (n=23), and was also performed on primary tumors and paired lymph node metastases (n=11). For all genes analyzed, only the PIK3R5 gene exhibited differential expression in samples of primary tumors with positive lymph node involvement compared with primary tumors with negative lymph node involvement (P=0.0347). These results demonstrate that the PIK3R5 gene may be considered predictive of lymph node involvement in breast carcinoma. Although the other genes evaluated in the present study have been previously characterized to be involved with the development of distant metastases, they did not have predictive potential.
dc.languageeng
dc.publisherSpandidos Publ Ltd
dc.relationOncology Letters
dc.relation0,599
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectbreast cancer
dc.subjectgene expression
dc.subjectlymph node metastases
dc.subjectmolecular markers
dc.subjectpredictive factors
dc.titleAnalysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución